Stig Lennart Hansson

Title: Stig Lennart Hansson: Innovator in Bile Salt-Stimulated Lipase Research

Introduction

Stig Lennart Hansson is a notable inventor based in Umeå, Sweden. He has made significant contributions to the field of biochemistry, particularly in the study of Bile Salt-Stimulated Lipase (BSSL). With a total of 3 patents, his work has implications for both medical and agricultural applications.

Latest Patents

Hansson's latest patents include groundbreaking inventions related to BSSL variants. The first patent, titled "Nucleic acids encoding BSSL variants," discloses nucleic acids that encode variant BSSL enzymes. These variants maintain catalytic activity while having fewer glycosylation sites than full-length BSSL. This reduction in glycosylation facilitates the purification and characterization of recombinant BSSL proteins.

The second patent, "Transgenic non-human mammals producing BSSL variants," relates to novel polypeptides that are variants of BSSL. This invention includes DNA molecules encoding these polypeptides and processes for producing transgenic non-human mammals capable of expressing the BSSL variants. Additionally, it covers the use of milk from these transgenic animals in infant formulas and pharmaceutical compositions.

Career Highlights

Throughout his career, Stig Lennart Hansson has worked with prominent companies such as Astra Aktiebolag and Aktiebolaget Astra. His experience in these organizations has contributed to his expertise in biochemistry and patent development.

Collaborations

Hansson has collaborated with notable individuals in his field, including Jan Birger Tornell and Lars Gustav Blackberg. These partnerships have likely enhanced his research and innovation capabilities.

Conclusion

Stig Lennart Hansson is a distinguished inventor whose work on Bile Salt-Stimulated Lipase variants has the potential to impact various industries. His patents reflect a commitment to advancing biochemistry and improving medical applications.